- AU$131.75m
- AU$103.06m
- AU$7.39m
- 69
- 30
- 66
- 58
Annual income statement for AML3D, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.644 | 2.01 | 0.634 | 7.32 | 7.39 |
| Cost of Revenue | |||||
| Gross Profit | 0.287 | 0.536 | 0.305 | 4.59 | 5.05 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.16 | 6.91 | 6.07 | 11.5 | 14.8 |
| Operating Profit | -5.51 | -4.9 | -5.44 | -4.17 | -7.4 |
| Net Income Before Taxes | -5.51 | -4.9 | -5.44 | -4.17 | -7.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.51 | -4.9 | -5.44 | -4.17 | -7.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.51 | -4.9 | -5.44 | -4.17 | -7.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.51 | -4.9 | -5.44 | -4.17 | -7.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.037 | -0.032 | -0.026 | -0.017 | -0.016 |